Pain is the most common presenting medical complaint and a significant risk factor for morbidity and mortality in many diseases. Substantial evidence suggests that pain's maladaptive effects on neuroendocrine and immune functioning constitute a primary pathway by which pain exerts its adverse effects (e.g., increasing the risk of cancer-related mortality). However, while much recent research has focused on treating acute and chronic pain, virtually no studies have included pain's physiological consequences as a primary outcome measure. This notable limitation of the existing literature is likely due in part to the absence of a systematically-validated laboratory pain model which investigators can use to study the effects of interventions on the immune and neuroendocrine concomitants of pain. The sequential studies proposed here will identify a laboratory pain model that reliably stimulates neuroendocrine and immunological alterations, and then obtain preliminary data on the effects of hypnosis on immune and neuroendocrine responses to acute pain. There is now strong evidence for the effectiveness of hypnotic analgesia in patients experiencing acute or chronic pain, but no studies have examined its efficacy in buffering pain's physiological impact. The initial phase of this research will systematically manipulate several parameters of commonly-used laboratory pain tests to establish a laboratory pain model that is well-tolerated and that reliably stimulates neuroendocrine and immune responses. The second phase, a pilot randomized controlled trial, will constitute a feasibility study of hypnotic analgesia's capacity to alter maladaptive neuroendocrine and immune responses to pain. Pain, especially chronic pain, has reached epidemic proportions around the world. Many of pain's adverse effects, ranging from depression to premature death, are at least partially due to pain's negative effects on several of the body's key physiological systems. Although much current research is aimed at finding treatments that reduce pain, very little is known about whether these treatments protect people from pain's negative physiological effects. This study will identify a method to evaluate these measures as outcomes, and will provide vital information related to the delivery of the hypnotic analgesia intervention and the overall protocol design, as well as allow examination of estimated effect sizes and possible subgroups who are more or less responsive to the intervention. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Center for Complementary & Alternative Medicine (NCCAM)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21AT003250-02
Application #
7282688
Study Section
Special Emphasis Panel (ZAT1-JH (15))
Program Officer
Stoney, Catherine
Project Start
2006-09-01
Project End
2009-08-31
Budget Start
2007-09-01
Budget End
2008-08-31
Support Year
2
Fiscal Year
2007
Total Cost
$172,428
Indirect Cost
Name
University of Maryland Balt CO Campus
Department
Psychology
Type
Schools of Arts and Sciences
DUNS #
061364808
City
Baltimore
State
MD
Country
United States
Zip Code
21250
Goodin, Burel R; Quinn, Noel B; Kronfli, Tarek et al. (2012) Experimental pain ratings and reactivity of cortisol and soluble tumor necrosis factor-? receptor II following a trial of hypnosis: results of a randomized controlled pilot study. Pain Med 13:29-44
Goodin, Burel R; Smith, Michael T; Quinn, Noel B et al. (2012) Poor sleep quality and exaggerated salivary cortisol reactivity to the cold pressor task predict greater acute pain severity in a non-clinical sample. Biol Psychol 91:36-41
Goodin, Burel R; Quinn, Noel B; King, Christopher D et al. (2012) Salivary cortisol and soluble tumor necrosis factor-? receptor II responses to multiple experimental modalities of acute pain. Psychophysiology 49:118-27
Goodin, Burel R; Quinn, Noel B; King, Christopher D et al. (2012) Enhanced cortisol increase upon awakening is associated with greater pain ratings but not salivary cortisol or soluble tumor necrosis factor-? receptor II responses to acute pain. Clin J Pain 28:291-9
Fabian, Lacy A; McGuire, Lynanne; Goodin, Burel R et al. (2011) Ethnicity, catastrophizing, and qualities of the pain experience. Pain Med 12:314-21
Jewett, Lisa R; Hudson, Marie; Haythornthwaite, Jennifer A et al. (2010) Development and validation of the brief-satisfaction with appearance scale for systemic sclerosis. Arthritis Care Res (Hoboken) 62:1779-86
Bento, S P; Goodin, B R; Fabian, L A et al. (2010) Perceived control moderates the influence of active coping on salivary cortisol response to acute pain among women but not men. Psychoneuroendocrinology 35:944-8
Goodin, Burel R; McGuire, Lynanne; Allshouse, Mark et al. (2009) Associations between catastrophizing and endogenous pain-inhibitory processes: sex differences. J Pain 10:180-90
Goodin, Burel R; McGuire, Lynanne M; Stapleton, Laura M et al. (2009) Pain catastrophizing mediates the relationship between self-reported strenuous exercise involvement and pain ratings: moderating role of anxiety sensitivity. Psychosom Med 71:1018-25
Knafo, Ruby; Thombs, Brett D; Jewett, Lisa et al. (2009) (Not) talking about sex: a systematic comparison of sexual impairment in women with systemic sclerosis and other chronic disease samples. Rheumatology (Oxford) 48:1300-3

Showing the most recent 10 out of 13 publications